NCT05879536View on ClinicalTrials.gov

The Effect of Intravenous Infusion of Tramadol-ondansetron on Recovery After Caesarean Section.

CompletedOBSERVATIONAL
Enrollment

312

Participants

Timeline

Start Date

May 23, 2023

Primary Completion Date

October 1, 2024

Study Completion Date

October 1, 2024

Conditions
Post Operative PainCesarean SectionTramadolPostoperative RecoveryQuality of RecoveryOndansetronQoR-15ObsQor-10Postcesarean Recovery
Interventions
DRUG

Tramadol-ondansetron continuous infusion

Analgesia strategy determined by routine use according to protocols, without investigator intervention.

DRUG

Ropivacaine via epidural catheter

Analgesia strategy determined by routine use according to protocols, without investigator intervention.

Trial Locations (1)

Unknown

Hospital Universitario La Fe, Valencia

All Listed Sponsors
lead

Hospital Universitario La Fe

OTHER

NCT05879536 - The Effect of Intravenous Infusion of Tramadol-ondansetron on Recovery After Caesarean Section. | Biotech Hunter | Biotech Hunter